‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JCO Oncology Practice Podcast
Cost and Survival Analysis before and after Implementation of Dana-Farber Clinical Pathways for Patients with Stage IV Non-Small Cell Lung Cancer
30
00:00:00
/ 00:13:38
30